We feel now is a pretty good time to analyse Vertex, Inc.'s ( NASDAQ:VERX ) business as it appears the company may ...

The economy has been on shaky ground for a while, and President Trump's tariffs and trade wars could finally send it into a ...

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions ...

KING OF PRUSSIA, Pa. - Vertex (NASDAQ:VRTX), Inc. (NASDAQ:VERX) shares tumbled 15.4% after the indirect tax solutions provider reported in-line fourth quarter results but issued disappointing ...

The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this. Whatever happens, though ...

The company remains a strong buy despite not performing in line with the market in the past six months. A big biotech company with multiple growth opportunities Keith Speights (Vertex Pharmaceuticals) ...

Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions ...

Vertex’s strong execution continued in the ... Cloud revenue now exceeds on-premise revenue for the first time in line with our strategic intent for future growth. NRR was 109%.

The 26 day EMA subtracted from the 12 day EMA alongwith the 9 day EMA which is the "signal line", together give buy/sell signals. If the MACD is above 0 and crosses above the signal line it is ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...